- Sickle cell disease (SCD) is
the common form of an inherited blood disorder
- Life expectancy of
people with SCD has normally been around 42-47 years
- Family support is the key
factor for long life expectancy and quality of life of the SCD patients
is Sickle Cell Disease (SCD)?
refers to a group of disorders affecting the structure
of hemoglobin. SCD
mutations produce abnormal hemoglobin
molecules called hemoglobin
S which causes sickle-shaped red blood cells with a tendency to agglutinate.
SCD is usually diagnosed within a
few months of birth with symptoms like anemia, frequent infections, pallor,
listlessness and irritability. The sickling red blood cells get stuck in blood
vessels and capillaries depriving major tissues and organs of blood
‘Longer life expectancy is possible for some sickle cell disease patients.’
This can lead to painful episodes
and complications like pulmonary hypertension (high blood pressure in the
lungs) and even heart failure
At present, there is no cure for
SCD though gene therapy
is in the research
Cell Disease (SCD) and Mortality
The World Health Organization
(WHO) declared SCD a public health priority. On an average there are nearly
300,000 live births/year. In developed countries such as the United States and
United Kingdom have worked towards reducing mortality from 3 to 0.13 per 100.
This has been possible with interventions such as newborn screening,
coordinated comprehensive care.
The life expectancy of people
with SCD has normally been around 42-47 years. Most mortality cases result from
organ damage, heart failure and strokes. However, a new report (Oct 2016)
published in Blood
, the journal of the American Society of Hematology
has shown that people with mild symptoms of SCD are now leading longer lives
with proper coordinated care, medicines and other therapeutic interventions.
The research paper uses four case studies of
women with mild SCD who have overtaken the median age of 47 years. These four
women are now around 85-86 years. These women received comprehensive care,
timely interventions and led healthy lifestyles. These four women can serve as
role models for people with SCD to take charge of their health and opt for
Three of the women were treated
at the Sickle Cell Center of Thomas Jefferson University while the other in
Brazil's Instituto de Hematologia Arthur de Siqueira Cavalcanti in Rio de
Janeiro. Two of these women had African-American ancestry, one had
Italian-American ancestry and the other had African-Brazilian ancestry.
According to the report author
Samir K. Ballas, MD, Professor Emeritus in the Department of Medicine at Sidney
Kimmel Medical College at Thomas Jefferson University in Philadelphia; the
can be attributed to a combination of lifestyle improvements, family support
and compliance with treatment. None of the women smoked and consumed very
little alcohol. They maintained a healthy weight with a normal body mass index
Since these women had mild SCD
symptoms they never received hydroxyurea (HU). They received blood transfusions
whenever required, adequate hydration, timely vaccinations and pain management.
Healthcare providers and support workers encouraged them to maintain healthy
body weight, avoid smoking and comply with treatment.
Dr. Ballas also reveals that these women did not present
with the usual severe complications accompanying SCD. The women never had
strokes or recurrent acute chest syndrome. They also had a higher level of
fetal hemoglobin and
had fewer painful episodes. However, they did have mild complications requiring
medical attention like occasional acute chest syndrome accompanied by fever,
cough, severe pain and breathlessness.
Dr. Ballas said that the report
had some limitations in that it had just four case studies and all were women.
Women may live longer because men with SCD tend to have higher blood viscosity.
However, men with SCD would benefit from these women's lifestyle improvements.
These four case studies give hope
to the SCD community who can also make similar lifestyle changes and stay on
top of their treatment plans and medical regimens. There is no reason why
people with SCD cannot live beyond 40 if they follow healthy lifestyles and
receive the right intervention at the right time.
- Sickle Cell Disease - General Information - (http://www.sicklecelldisease.org/)
- Mortality in Sickle Cell Anemia in Africa: A Prospective Cohort Study in Tanzania - (http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0014699)
- About Sickle Cell Disease - (https:ghr.nlm.nih.gov/condition/sickle-cell-disease)
- Case Series of Octogenarians with Sickle Cell Disease - (http://www.bloodjournal.org/content/early/2016/10/03/blood-2016-05-715946?sso-checked=true)